EVORION Biotechnologies

@EVORIONBiotech

Accelerating high-performance live-cell analysis systems to enable cell-based therapies. "Each cell in the spotlight"

Münster, Germany
Vrijeme pridruživanja: studeni 2019.

Tweetovi

Blokirali ste korisnika/cu @EVORIONBiotech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EVORIONBiotech

  1. Prikvačeni tweet
    Poništi
  2. 4. velj

    Thanks, for organizing breakfast together and fostering discussions and collaborations among different companies. , glad to be the part of the big family.

    Poništi
  3. 29. sij
    Poništi
  4. proslijedio/la je Tweet
    27. sij

    British scientists accidentally discover cancer breakthrough

    Poništi
  5. 23. sij

    Thank you for fruitful discussions and meetings. We have started to follow up with the conference outcomes and activities to turn into great opportunities ahead.

    Poništi
  6. proslijedio/la je Tweet

    Dozens of non-oncology drugs can kill cancer cells, according to a new study. This study marks the first time researchers screened the entire collection of mostly non-cancer drugs for their anti-cancer capabilities.

    Poništi
  7. proslijedio/la je Tweet
    8. sij

    Abstract submission is open for Europe’s Meeting! The 18th Annual Meeting will take place 5-7 May in Mainz. Register by February 28 to experience speakers such as Ping-Chih Ho, Yardena Samuels and Laurence Zitvogel!

    Poništi
  8. proslijedio/la je Tweet

    Where do we see the most innovation among immunotherapy drug classes? We have updated our IO landscape just in time for :

    Poništi
  9. proslijedio/la je Tweet

    The most powerful use of CRISPR isn’t in gene editing, says Steven Wiley.

    Poništi
  10. 8. sij

    We have created an innovative microfluidic-chip based technology that enables multiparametric live analysis at single-cell resolution to target key applications in the immune-oncology space & beyond. Let's catch up. Please write to us at JMP@evorion.de

    Poništi
  11. Are you a enthusiast? Check out our microfluidic Christmas tree on a to enjoy your festive season. We wish you all a great .

    Poništi
  12. Therapy review in 2019. Looking forward to more developments in 2020.

    Poništi
  13. proslijedio/la je Tweet
    16. pro 2019.

    Identifying the source of tumour-infiltrating

    Poništi
  14. We will be around in San Francisco during the J.P. Morgan Healthcare Conference 2020. Get insights into our cutting-edge technology to revolutionize research & development in the space & beyond. Write us at JMP@evorion.de

    Poništi
  15. What a great day it was at workshop "Future in medicine - innovative cell and gene therapies" , . Thanks, for organizing it and now we, are also listed on company directory 2020. Do check it out.

    Poništi
  16. proslijedio/la je Tweet
    3. pro 2019.

    "Future in Medicine" präsentiert in der -Landesvertretung in von in Kooperation mit .

    Poništi
  17. proslijedio/la je Tweet

    Beating cancer: How viruses are being used to infect and kill tumours

    Poništi
  18. Meet our CEO, Dr. Sebastian Bühren and CTO, Hans Kleine-Brüggeney to discuss future partnership and collaboration in building together a great platform for developing innovate cell therapies to fight cancer. Thanks,

    Poništi
  19. Glad to be a part of Centre for Nanobioanalytics

    Poništi
  20. proslijedio/la je Tweet
    7. ožu 2019.

    Dr. Bühren : Path for Funding; from grants to private equity, 2016 - 2021 etc.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·